Infliximab (Remicade) is a chimeric monoclonal antibody against tumor necrosis factor alpha (TNF-alpha). Infliximab neutralizes the biological activity of TNF-alpha by binding with high affinity to the soluble (free floating in the blood) and transmembr
* VAT and and shipping costs not included. Errors and price changes excepted